imciromab pentetate (myoscint) Report issue

Biologics mAb Imaging Approved FDA
ChEMBL DrugBank Drugs@FDA MeSH PubChem

Active Ingredient History

NOW
  • Now
Indium (111In) imciromab is a mouse monoclonal antibody labelled with the radioisotope Indium-111. It was used for cardiac imaging, but withdrawn in 1993.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: No
  • Imaging: 111-Indium
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

(111)indium-labeled antimyosin antibody | c-4 | imciromab | imciromab (111in) | imciromab in111 | imciromab pentetate | imciromab pentetate, radiolabeled product | indio-111-antiomiosina | indium-111-antimyosin | indium-111-antimyosin fab | indium (111in) imciromab | indium (111in) imciromab pentetate | indium antimyosin | indium in 111 imciromab pentetate | indium in-111 imciromab pentetate | indium in-111 myoscint | myoscint | myoscint indium in-111 | r1d10

Organizations (1)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (1)


 

Diagnostic Imaging (approved 1996)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue